Literature DB >> 9726042

Endolymphatic sac tumours.

G Kempermann1, H P Neumann, B Volk.   

Abstract

This review article surveys clinical and pathological literature on endolymphatic sac tumours (ELST) and summarizes characteristics that describe the entity. ELST are rare neuroectodermal neoplasms in the petrous bone, originating from inner ear structures. They can be encountered sporadically or in von Hippel-Lindau disease. The most prominent symptom is sensorineural deafness. Historically, nomenclature of invasive adenoid tumours in the petrous bone has been divergent, the term papillary adenocarcinoma used most frequently. Histologically, they have a follicular or papillary and adenoid pattern that can be easily confused with various other neoplastic conditions including metastatic carcinoma. It remains to be verified whether similar tumours (papillary adenocarcinomas) can originate from the middle ear. Middle ear adenomas have a similar appearance but probably originate from neural crest cells in the middle ear. ELST can express a variety of epitopes (including cytokeratin and neuroectodermal markers) which can be detected immunohistochemically. In cases in von Hippel-Lindau disease the cerebello-pontine angle should be included in routine radiological examinations to detect ELST before the tumours lead to deafness. In apparently sporadic cases of ELST, genetic testing for von Hippel-Lindau disease should be considered. Correct distinction of ELST from metastatic carcinoma prevents futile searches for unknown primary tumours.

Entities:  

Mesh:

Year:  1998        PMID: 9726042     DOI: 10.1046/j.1365-2559.1998.00460.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  15 in total

1.  Spinal metastasis from endolymphatic sac tumor.

Authors:  K Y Tay; E Yu; E Kassel
Journal:  AJNR Am J Neuroradiol       Date:  2007-04       Impact factor: 3.825

2.  Magnetic resonance and computed tomography imaging of a grade IV papillary endolymphatic sac tumour.

Authors:  Pieter Janse van Rensburg; Graeme van der Meer
Journal:  J Neurooncol       Date:  2008-05-07       Impact factor: 4.130

3.  Adenomatous tumors of the middle ear and temporal bone: clinical, morphological and tumor biological characteristics of challenging neoplastic lesions.

Authors:  M Duderstadt; Christine Förster; H-J Welkoborsky; H Ostertag
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-24       Impact factor: 2.503

Review 4.  Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features.

Authors:  Sven Gläsker
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  Clinicoradiologic characteristics of endolymphatic sac tumors.

Authors:  Hongbo Le; Huihong Zhang; Weijing Tao; Lan Lin; Jie Li; Lin Ma; Guobin Hong; Xin Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-13       Impact factor: 2.503

6.  Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications.

Authors:  H Jeffrey Kim; Marygrace Hagan; John A Butman; Martin Baggenstos; Carmen Brewer; Christopher Zalewski; W Marston Linehan; Russell R Lonser
Journal:  Laryngoscope       Date:  2012-10-15       Impact factor: 3.325

7.  Endolymphatic sac tumors : report of four cases.

Authors:  Chae Wan Bae; Young Hyun Cho; Jong Woo Chung; Chang Jin Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-10-30

8.  Endolymphatic sac tumors: experience of three cases.

Authors:  Pierre-Louis Bastier; Erwan de Mones; Magali Marro; Wael Elkhatib; Valérie Franco-Vidal; Dominique Liguoro; Vincent Darrouzet
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-05       Impact factor: 2.503

9.  Tumors and pseudotumors of the endolymphatic sac.

Authors:  Rodney C Diaz; Esmael H Amjad; Eric W Sargent; Michael J Larouere; Wayne T Shaia
Journal:  Skull Base       Date:  2007-11

10.  Treatment of endolymphatic sac tumour (Papillary adenocarcinoma) of the temporal bone.

Authors:  Arturo Mario Poletti; Siba Prasad Dubey; Giovanni Colombo; Giovanni Cugini; Antonio Mazzoni
Journal:  Rep Pract Oncol Radiother       Date:  2015-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.